greggerypeccary
|
Lisa Jones wrote on Mar 28 th, 2022 at 7:10am: greggerypeccary wrote on Mar 27 th, 2022 at 9:08pm: Frank wrote on Mar 27 th, 2022 at 7:58pm: greggerypeccary wrote on Mar 27 th, 2022 at 7:49pm: “Coronary artery calcium definitely deserves a place in the guidelines for use,” he said. “I think there has been a significant amount of evidence that shows a coronary calcium score improves risk prediction of who is going to have events better than any other biomarker or test . . . . It can tell you who might have lower risk than you previously thought or who might be at higher risk than you thought. When compared with any other test that we have, it has a better ability to accurately predict those events.”Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study ShowsIn the new study, which was published online October 31, 2018, ahead of print in the Journal of American College of Cardiology, researchers conducted a retrospective analysis of 13,644 patients who underwent coronary artery calcium (CAC) screening between 2002 and 2009 at Walter Reed Army Medical Center to determine the effects of statins on cardiovascular events. Overall, patients had a low burden of risk factors for atherosclerotic cardiovascular disease (ASCVD) and more than two-thirds had no detectable CAC. Of those included in the analysis, 6,886 were treated with a statin, with nearly half of these patients prescribed the lipid-lowering therapy in the 6 months before the CAC test. Two-thirds of patients were treated with a moderate-intensity statin and 19.3% received a high-intensity statin. The median follow-up was 9.4 years. In an analysis comparing patients positive or negative for coronary calcium (any amount greater than zero), patients with detectable CAC prescribed a statin had a 24% lower relative risk of MI, stroke, or cardiovascular death when compared with those with evidence of CAC not treated with a statin (adjusted subhazard ratio 0.76; 95% CI 0.60-0.95). In contrast, among patients with no evidence of calcification (CAC score = 0), there was no difference in the risk of major cardiovascular events among those treated with a statin compared with those not treated with a statin. Yep. That's what I said. Soooo... gweggy tujd is revolting against medical advice about statins ... No, I'm following the medical advice. I suggest you read the medical study again. It backs me up 100%. Is English your first language? I'm curious. Oh God! Emucorp STFU! You've been pwned good and proper. No one cares about some stupid googled study you found whilst superglued to that multi cyber junkie troll chair of yours.
You've got a lot of health issues yourself. Mental and Physical. Sort yourself out FIRST before pretending to play doctor online.
Idiot! “Coronary artery calcium definitely deserves a place in the guidelines for use,” he said. “I think there has been a significant amount of evidence that shows a coronary calcium score improves risk prediction of who is going to have events better than any other biomarker or test . . . . It can tell you who might have lower risk than you previously thought or who might be at higher risk than you thought. When compared with any other test that we have, it has a better ability to accurately predict those events.”Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study ShowsIn the new study, which was published online October 31, 2018, ahead of print in the Journal of American College of Cardiology, researchers conducted a retrospective analysis of 13,644 patients who underwent coronary artery calcium (CAC) screening between 2002 and 2009 at Walter Reed Army Medical Center to determine the effects of statins on cardiovascular events. Overall, patients had a low burden of risk factors for atherosclerotic cardiovascular disease (ASCVD) and more than two-thirds had no detectable CAC. Of those included in the analysis, 6,886 were treated with a statin, with nearly half of these patients prescribed the lipid-lowering therapy in the 6 months before the CAC test. Two-thirds of patients were treated with a moderate-intensity statin and 19.3% received a high-intensity statin. The median follow-up was 9.4 years. In an analysis comparing patients positive or negative for coronary calcium (any amount greater than zero), patients with detectable CAC prescribed a statin had a 24% lower relative risk of MI, stroke, or cardiovascular death when compared with those with evidence of CAC not treated with a statin (adjusted subhazard ratio 0.76; 95% CI 0.60-0.95). In contrast, among patients with no evidence of calcification (CAC score = 0), there was no difference in the risk of major cardiovascular events among those treated with a statin compared with those not treated with a statin. Yep. That's what I said.
|